Elizabeth A. Garofalo - May 29, 2025 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
Director
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
Stock symbol
ACAD
Transactions as of
May 29, 2025
Transactions value $
$0
Form type
4
Date filed
6/2/2025, 06:05 PM
Previous filing
Mar 6, 2025
Next filing
Jun 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GAROFALO ELIZABETH A. Director C/O ACADIA PHARMACEUTICALS INC., 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO /s/ Jennifer J. Rhodes, Attorney-in-Fact 2025-06-02 0001826361

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACAD Common Stock Options Exercise +9.39K +53.35% 27K May 29, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Restricted Stock Units Options Exercise $0 -9.39K -100% $0.00 0 May 29, 2025 Common Stock 9.39K Direct F1, F2
transaction ACAD Director Stock Options (Right to Buy) Award $0 +13.8K $0.00 13.8K May 29, 2025 Common Stock 13.8K $22.29 Direct F3
transaction ACAD Restricted Stock Units Award $0 +8.11K $0.00 8.11K May 29, 2025 Common Stock 8.11K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
F2 The restricted stock units vested in full on May 29, 2025, the date on which an annual meeting of stockholders was held.
F3 The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders.
F4 The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders.